[Laboratory control of fibrinolytic therapy].
The mode of action of the different thrombolytic substances which are presently available is described. Alterations of the clotting mechanism which are to be expected during thrombolytic therapy as well as possible side effects of the fibrinolytic drugs are listed. Laboratory tests necessary for the control of thrombolytic therapy as well as the different test methods and their normal ranges are mentioned in detail.
D001780:Blood Coagulation Tests; D005340:Fibrinogen / Q000502:physiology; D005341:Fibrinolysin / Q000627:therapeutic use*; D005342:Fibrinolysis; D006801:Humans; D010958:Plasminogen / Q000502:physiology; D010960:Plasminogen Activators / Q000627:therapeutic use*; D013300:Streptokinase / Q000627:therapeutic use*; D013927:Thrombosis / Q000097:blood / Q000188:drug therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D005340:Fibrinogen; D010958:Plasminogen; D013300:Streptokinase; D010960:Plasminogen Activators; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator
Laborkontrolle der fibrinolytischen Therapie.